Investo Capital

Dryp is a technology company based in Copenhagen, Denmark, that specializes in IoT-enabled wireless sensors for real-time water data collection. Established in 2019, Dryp utilizes a combination of hydrology, data science, and artificial intelligence to enhance smart water management. The company's sensors provide valuable insights by detecting leaks and monitoring water distribution across networks. This capability allows clients to optimize their water facilities and make informed decisions about water management. Dryp's approach aims to transform wastewater into a resource while minimizing the climate footprint associated with urban water systems.

Nilroy specializes in the design and manufacturing of custom cooker hood products, focusing on innovative solutions that prioritize low energy consumption through advanced airflow design. The company offers hand-made hoods crafted by skilled Danish artisans, providing an alternative to traditional kitchen hoods. Nilroy caters to both private and business customers, allowing them to personalize their hoods according to specific material preferences and measurements, ensuring a tailored fit for any kitchen. Through its commitment to quality craftsmanship and efficiency, Nilroy delivers unique kitchen solutions that blend functionality with aesthetic appeal.

VentriJect is a medical device company focused on enhancing health assessments by integrating cardiorespiratory fitness measurements into routine checkups. The company's innovative device is positioned on the distal part of the chest and connects to a smartphone application to facilitate a quick and reliable estimation of cardiorespiratory fitness. This process allows users to receive heart health insights within seconds, as the data is transmitted to a laboratory for interpretation. By providing a convenient method for assessing respiratory fitness, VentriJect aims to empower individuals to monitor and improve their overall cardiovascular health without needing to visit a hospital or laboratory.

Create It REAL Aps is a Danish company based in Aalborg, specializing in 3D printing technologies. Founded in 2009, it develops advanced electronics kits for 3D printers aimed at manufacturers and startups, alongside a suite of software solutions to streamline the 3D printing process. Its offerings include REALvision, a comprehensive slicing software available in various formats, including desktop, cross-platform, and web-based applications. The company also designs small and industrial-sized 3D printers tailored to customer needs and provides consulting services for businesses looking to integrate additive manufacturing into their operations. With a team of experts in 3D printing, electronics, and product development, Create It REAL focuses on creating user-friendly solutions that reduce complexity and accelerate time to market for its clients. The company's innovations enhance the speed and security of 3D printing while accommodating the specific requirements of manufacturers.

Tentoma, originally founded in 2011 as Frank Bruhn ApS, has evolved from providing service and maintenance in the vertical stretch hood industry to becoming an international supplier of horizontal stretch film packaging solutions. The company specializes in manufacturing fully automatic packaging machines designed to securely pack larger goods, thereby protecting them from water and contamination. Tentoma's innovative in-line horizontal tube stretch packaging machines enhance packaging quality and profitability for businesses, enabling them to safeguard their products from damage while streamlining the packaging process.

Brainreader, founded in 2011 as a spin-off from Aarhus University, specializes in developing advanced software for the structural analysis of MRI scans to aid in the diagnosis of neurological diseases. Its flagship product, Neuroreader™, leverages research indicating that low hippocampal volume is a significant marker for the progression of cognitive impairment to Alzheimer's disease and dementia. The software offers healthcare professionals a comprehensive assessment by processing MRI scans and generating user-friendly reports that include total brain volume, hippocampal volume, and volumetric data compared to a healthy database. Brainreader aims to establish Neuroreader™ as the preferred tool for physicians and MRI clinics globally, with the vision of providing objective, precise, and personalized analysis of brain scans. This innovation seeks to enhance patient quality of life while also reducing the societal costs associated with neurological diseases.

TracInnovations is a medical technology company focused on enhancing image-based diagnostics and treatment through innovative motion tracking solutions. The company has developed a sophisticated motion tracker and monitor system that accurately records patients' head movements during brain scans, facilitating improved diagnostic and treatment processes. Their flagship product, the tracoline system, utilizes a 3D stereo vision approach to provide reliable tracking quality and real-time motion feedback, enabling a user-friendly setup for both patients and healthcare professionals. By streamlining the process of monitoring patient movements, TracInnovations aims to support physicians in delivering effective and precise treatments.

Brainreader, founded in 2011 as a spin-off from Aarhus University, specializes in developing advanced software for the structural analysis of MRI scans to aid in the diagnosis of neurological diseases. Its flagship product, Neuroreader™, leverages research indicating that low hippocampal volume is a significant marker for the progression of cognitive impairment to Alzheimer's disease and dementia. The software offers healthcare professionals a comprehensive assessment by processing MRI scans and generating user-friendly reports that include total brain volume, hippocampal volume, and volumetric data compared to a healthy database. Brainreader aims to establish Neuroreader™ as the preferred tool for physicians and MRI clinics globally, with the vision of providing objective, precise, and personalized analysis of brain scans. This innovation seeks to enhance patient quality of life while also reducing the societal costs associated with neurological diseases.